Intrepida Bio Competitors and Similar CompaniesClear all
Curis's competitors and similar companies include ADC Therapeutics.
 Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. |  ADC Therapeutics ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers. | |
Founding Date | Founding Date 2000 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lexington, US HQ Lexington, US | Locations Epalinges, CH HQ London, GB New Providence, US |
Employees | Employees 3144% decrease | Employees 1162% increase |
Valuation ($) | Valuation ($) 29.4 m | Valuation ($) 295.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $9.4m (FY, 2025) | Revenue (est.) $81.4m (FY, 2025) |
Net income | Net income ($7.6m) (FY, 2025) | Net income ($142.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
ADC Therapeutics
HQ
Epalinges, CH
Employees
116↑ 2% increase
ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.
View company